167 related articles for article (PubMed ID: 38553949)
21. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
[No Abstract] [Full Text] [Related]
22. Operative Versus Nonoperative Management of Nonfunctioning Pancreatic Neuroendocrine Tumors.
Zhang IY; Zhao J; Fernandez-Del Castillo C; Braun Y; Razmdjou S; Warshaw AL; Lillemoe KD; Ferrone CR
J Gastrointest Surg; 2016 Feb; 20(2):277-83. PubMed ID: 26691146
[TBL] [Abstract][Full Text] [Related]
23. Prediction of Tumor Prognosis of Pancreatic Neuroendocrine Tumors Using Image, Surgical and Pathologic Findings.
Chen F; Huang Y; Chen C; Zhang Y; Zhang Y; Wan R; Xu M
Neuro Endocrinol Lett; 2023 Oct; 44(7):453-464. PubMed ID: 37874552
[TBL] [Abstract][Full Text] [Related]
24. The prognostic effect of the systemic immune-inflammation index on overall survival of periampullary cancer.
Yur M; Balin ŞÖ; Aygen E; Ilhan YS; Yilmaz S; Ebiloğlu MF
Curr Med Res Opin; 2023 Aug; 39(8):1139-1145. PubMed ID: 37470473
[TBL] [Abstract][Full Text] [Related]
25. Association of preoperative monocyte-to-lymphocyte and neutrophil-to-lymphocyte ratio with recurrence-free and overall survival after resection of pancreatic neuroendocrine tumors (US-NETSG).
Panni RZ; Lopez-Aguiar AG; Liu J; Poultsides GA; Rocha FG; Hawkins WG; Strasberg SM; Trikalinos NA; Maithel S; Fields RC;
J Surg Oncol; 2019 Sep; 120(4):632-638. PubMed ID: 31339198
[TBL] [Abstract][Full Text] [Related]
26. Prognostic role and predictors of lymph node involvement in pancreatic neuroendocrine tumors.
Ren SJ; Tan QQ; Cao D; Ke NW; Liu XB; Wang X
Eur J Radiol; 2023 May; 162():110772. PubMed ID: 36940547
[TBL] [Abstract][Full Text] [Related]
27. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgically Resectable Pancreatic Neuroendocrine Tumors.
Zhou B; Zhan C; Wu J; Liu J; Zhou J; Zheng S
Med Sci Monit; 2017 Nov; 23():5574-5588. PubMed ID: 29168979
[TBL] [Abstract][Full Text] [Related]
29. Prognostic predictors for recurrence following curative resection in grade I/II pancreatic neuroendocrine tumours.
Chopde A; Gupta A; Chaudhari V; Parghane R; Basu S; Ostwal V; Ramaswamy A; Puranik A; Shrikhande SV; Bhandare MS
Langenbecks Arch Surg; 2023 May; 408(1):204. PubMed ID: 37212896
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of systemic immune-inflammation index and platelet-albumin-bilirubin grade in patients with pancreatic cancer undergoing radical surgery.
Han R; Tian Z; Jiang Y; Guan G; Sun X; Yu Y; Zhang L; Zhou J; Jing X
Gland Surg; 2022 Mar; 11(3):576-587. PubMed ID: 35402206
[TBL] [Abstract][Full Text] [Related]
31. Prognostic and clinicopathological significance of systemic immune-inflammation index in pancreatic cancer: a meta-analysis of 2,365 patients.
Shui Y; Li M; Su J; Chen M; Gu X; Guo W
Aging (Albany NY); 2021 Aug; 13(16):20585-20597. PubMed ID: 34435973
[TBL] [Abstract][Full Text] [Related]
32. Vascularity and Tumor Size are Significant Predictors for Recurrence after Resection of a Pancreatic Neuroendocrine Tumor.
Yamamoto Y; Okamura Y; Uemura S; Sugiura T; Ito T; Ashida R; Kato Y; Ohgi K; Yamada M; Sasaki K; Aramaki T; Uesaka K
Ann Surg Oncol; 2017 Aug; 24(8):2363-2370. PubMed ID: 28271173
[TBL] [Abstract][Full Text] [Related]
33. The Relationship Between Preoperative Systemic Immune Inflammation Index and Prognostic Nutritional Index and the Prognosis of Patients With Alveolar Hydatid Disease.
Ren B; Chen X; Lei P; Hou L; Wang H; Zhou Y; Ren L; Fan H; Wang Z; Yuan J
Front Immunol; 2021; 12():691364. PubMed ID: 34248983
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Value of the C-Reactive Protein/Albumin Ratio and Systemic Immune-Inflammation Index for Patients With Colorectal Liver Metastasis Undergoing Curative Resection.
Deng Y; Zhao Y; Qin J; Huang X; Wu R; Zhou C; Pan Z
Pathol Oncol Res; 2021; 27():633480. PubMed ID: 34257601
[No Abstract] [Full Text] [Related]
35. High vimentin expression with E-cadherin expression loss predicts a poor prognosis after resection of grade 1 and 2 pancreatic neuroendocrine tumors.
Zhou B; Xiang J; Jin M; Zheng X; Li G; Yan S
BMC Cancer; 2021 Mar; 21(1):334. PubMed ID: 33789624
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of prognostic nutritional index and systemic immune-inflammation index in patients with osteosarcoma.
Huang X; Hu H; Zhang W; Shao Z
J Cell Physiol; 2019 Aug; 234(10):18408-18414. PubMed ID: 30891768
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of systemic ımmune ınflammation ındex in patients with laryngeal cancer.
Atasever Akkas E; Yucel B
Eur Arch Otorhinolaryngol; 2021 Jun; 278(6):1945-1955. PubMed ID: 33837464
[TBL] [Abstract][Full Text] [Related]
38. Systemic immune-inflammation index predicts prognosis of patients with advanced pancreatic cancer.
Zhang K; Hua YQ; Wang D; Chen LY; Wu CJ; Chen Z; Liu LM; Chen H
J Transl Med; 2019 Jan; 17(1):30. PubMed ID: 30658662
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Tumor Markers for Predicting Disease-Free Survival in Surgically Resected Pancreatic Neuroendocrine Tumors.
Zhou B; Fang B; Yan S; Wang W
Clin Lab; 2017 Jul; 63(7):1251-1259. PubMed ID: 28792692
[TBL] [Abstract][Full Text] [Related]
40. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer.
Tong YS; Tan J; Zhou XL; Song YQ; Song YJ
J Transl Med; 2017 Oct; 15(1):221. PubMed ID: 29089030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]